The Filing Desk

United States Antimony

UAMY · NYSE · Materials · Financials, fiscal 2016 to 2025

UAMY · Last close · November 13, 2026
$3.09
Value United States Antimony yourself

United States Antimony's revenue rose 162.8% to $39 million in fiscal 2025. Its operating margin was −21.6%, down from −16.0% a year earlier. Free cash flow was −$38 million, against $2 million a year earlier. It paid out $0 million in dividends and buybacks. The diluted share count rose 13.8%.

UNITED STATES ANTIMONY CORPORATION Latest fiscal year ended December 31, 2025 10-K filed March 19, 2026 · 0001104659-26-032049 Updated
Revenue
$39M
162.8%
Operating margin
−21.6%
5.6 pts
Net income
−$4M
 
Free cash flow
−$38M
$2M a year earlier
Return on capital
−11.0%
4.5 pts
Market cap
$462M
Nov 13 close
P/E
—
Loss: no P/E

Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on capital is after-tax operating income as a share of the money invested in the business: debt plus equity, minus cash. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.

Charts show fiscal years, from the 10-K filings.

What United States Antimony does

United States Antimony Corporation mines, buys, processes and sells antimony and precious metals, mainly gold and silver, in Montana and Mexico. It also mines, processes and sells zeolite in Idaho. Antimony and zeolite are minerals used in many industrial, commercial and government applications, and the company sells them in processed forms ready for end use.

It began operating in Montana in 1970. Antimony mining in the United States stopped in the 1980s as cheaper imported ore came in. The company kept processing ore bought from foreign suppliers into antimony trioxide, antimony metal and antimony trisulfide, and in 2025 it again mined its own antimony ore in Montana. It also processes antimony ore at two facilities in Mexico.

In late 2024 and 2025 it acquired mining claims in Alaska, Montana and Canada that may hold antimony, tungsten, cobalt and other critical minerals. It is finishing an expansion of its Montana antimony plant that is expected to more than triple its capacity. The added supply is meant to serve two new five-year sales contracts, with the U.S. Defense Logistics Agency and an industrial customer, signed in 2025.

Its biggest risks, as it describes them

  • It has lost money in recent years and may keep doing so.
  • U.S. trade policy changes, including tariffs and retaliatory tariffs, could hurt its business.
  • It may need more financing, which may not be available on acceptable terms.
  • A drop in metals prices, mine accidents or higher costs could force it to write down assets.
  • Its mining may not prove economically viable, and its environmental cleanup obligations may exceed what it has set aside.
From United States Antimony's annual report on Form 10-K, filed March 19, 2026, in our words; the 10-K has the full description and every risk factor. Updated with each new annual report.

Income statement

Revenue and net income
US$ billions, fiscal years; net losses in red. Revenue on the left axis, net income on the right; zero is the same line on both.
Revenue (left axis)Net income (right axis)
Gross profit, R&D and operating income
US$ billions, fiscal years. Gross profit is revenue minus the cost of what was sold; research and development is one of the costs paid from it; what remains after all operating costs is operating income. Losses in red.
Gross profitResearch and developmentOperating income
Margins
Percent of revenue
GrossOperatingNetFree cash flow

United States Antimony lost money in fiscal 2025: a net loss of $4 million.

Diluted earnings per share
US$ per share, fiscal years, restated for any stock splits; loss years in red. Where the filings' structured data doesn't give a year's earnings per share, the column is blank.

Returns on capital

Return on capital and on equity
Percent. Return on capital is after-tax operating income over the money invested in the business (debt plus equity, minus cash); return on equity is net income over shareholders' equity. Both use the average of opening and closing balances.
Return on capitalReturn on equity

Balance sheet

Cash and debt
US$ billions, at each fiscal year end. Debt includes finance leases.
Cash and short-term investmentsDebt
Assets, liabilities and equity
US$ billions, at each fiscal year end. Assets equal liabilities plus equity; negative equity in red.
Total assetsTotal liabilitiesShareholders' equity
Debt and liquidity ratios
Times. Debt to equity, current assets over current liabilities, and net debt over EBITDA (a full year's).
Debt to equityCurrent ratioNet debt to EBITDA

Five years at a glance

Fiscal year endFY21FY22FY23FY24FY25
Cash and short-term investments2119121830
Debt incl. finance leases00000
Net debt (negative means net cash)−21−19−12−18−30
Net debt to EBITDA−95.9x−15.0x———
Debt to equity0.0x0.0x0.0x0.0x0.0x
Interest coverage−119.2x23.0x−671.9x−269.6x−507.9x
Current ratio11.4x9.7x15.7x5.2x5.4x
Quick ratio10.9x9.1x14.1x4.8x4.2x
US$ millions unless stated, at each fiscal year end. Net debt to EBITDA is debt minus cash, divided by operating income before depreciation and amortization: roughly how many years of those earnings the net debt equals. Debt to equity is debt as a multiple of shareholders' equity. Interest coverage is operating income divided by interest expense. The current ratio is current assets over current liabilities; the quick ratio leaves out inventory.

Cash flow

Cash from operations, capital spending and free cash flow
US$ billions, fiscal years. Free cash flow is cash from operations minus capital spending; negative years in red.
Cash from operationsCapital spendingFree cash flow
Stock-based compensation and buybacks
US$ billions, fiscal years. Shares paid to employees (stock-based compensation, a cost that uses no cash) against cash spent buying shares back. Buybacks that only match it leave the share count roughly where it was.
Stock-based compensationShare buybacks
Dividends and buybacks
US$ billions, cash paid in each fiscal year
DividendsShare buybacks
Diluted share count
Weighted-average diluted shares, millions

Projections

Project United States Antimony's revenue, net income and earnings per share five years ahead in a bull, a base and a bear case with your own figures, and see the share prices your P/E estimates give them, or value it with a discounted cash flow model. Every projected figure is yours: it is not a forecast of ours.

What United States Antimony says to expect

  • Full year 2026: antimony sales volumeFor full-year 2026, the Company expects to sell approximately 1.68 million to 1.81 million pounds of antimony, compared with approximately 1.41 million pounds in 2025, an increase of approximately 24% at the midpoint.
The company's own words, from its earnings release (Form 8-K, Exhibit 99), filed November 12, 2026. They are its expectations, not ours, and not a forecast or price target from The Filing Desk. Replaced when the next release is out.

Insider trades

Over the 12 months between November 14, 2025 and November 13, 2026, 5 insiders bought $391,917 of United States Antimony shares on the open market, and none sold any.

Buys and sells by month
US$ millions, open-market purchases (up) and sales (down) by officers, directors and 10% owners in each month.
BoughtSold
DateInsiderTradeSharesPriceValueFiling
Sep 1, 2026Joseph A CarrabbaDirectorBought21,300$4.72$100,536Form 4
Sep 1, 2026Lloyd BardswichDir, EVP & Chief Mining Eng, DirectorBought20,000$4.64$92,800Form 4
Aug 31, 2026Blaise A. AguirreDirectorBought1,400$5.04$7,056Form 4
Aug 28, 2026Gary C EvansChairman & CEO, DirectorBought20,000$4.92$98,400Form 4
Jun 15, 2026Jon R MarinelliDirectorBought12,500$7.45$93,125Form 4
Open-market purchases and sales by officers, directors and 10% owners, from their Form 4 filings with the SEC: one row per person, day and filing, at the day's average price. Grants, option exercises and shares withheld for tax aren't counted. Insiders buy and sell for many reasons, such as taxes, spreading their savings or a plan set up months earlier, so a trade on its own says little about where a company is heading. For information only, not investment advice. Insider trades at all companies

Indicators

Four widely used measures, worked out from the company's filings. The cutoffs are the ones their authors or users go by, not a verdict of ours.

IndicatorFY23FY24FY25
Piotroski F-score3 of 95 of 94 of 9
Rule of 40−93.5%83.8%67.3%
Altman Z''7.223.7911.98
Accruals ratio−5.1%−12.6%5.7%
Piotroski F-score: how many of nine simple tests of profitability, funding and efficiency the company passed in the year (Piotroski, 2000); 8 or 9 is strong, 0 to 2 weak. Rule of 40: revenue growth plus free cash flow margin; software investors treat 40% or more as the bar. Altman Z'': working capital, retained earnings, operating income and equity weighed against assets and liabilities (Altman, 1995); Altman puts above 2.6 in the safe zone and below 1.1 in the distress zone. Accruals ratio: net income minus cash from operations, over average total assets; lower means profit is backed by cash.

The nine F-score tests

TestFY23FY24FY25
Net income is positiveFailFailFail
Cash from operations is positiveFailPassFail
Return on assets roseFailPassFail
Cash from operations exceeds net incomePassPassFail
Debt fell relative to assetsPassFailPass
Current ratio rosePassFailPass
Share count didn't riseFailFailFail
Gross margin roseFailPassPass
Revenue rose relative to assetsFailPassPass
F-score3 of 95 of 94 of 9
Companies that report no gross profit are scored on the other eight.

Compare

Put United States Antimony side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.

Similar companies

CompanyYearRevenue growthOperating marginFree cash flow marginReturn on capitalNet debt to EBITDAF-scoreCompare
United States AntimonyFY25162.8%−21.6%−95.5%−11.0%—4
American Battery Technology CompanyFY26406.8%−343.6%−167.1%———Compare
MP MaterialsFY2510.1%−66.5%−146.2%−10.4%—3Compare
Ivanhoe ElectricFY2511.8%−3,501.0%−2,786.8%−34.1%—5Compare
RealloysFY25−5.3%−165.7%—−57.0%—2Compare
Each company's latest fiscal year. Fiscal years end in different months, so the periods don't line up exactly. Free cash flow margin is free cash flow as a share of revenue. Net debt to EBITDA is explained under the balance sheet, and the F-score under Indicators.

10 years of figures

Fiscal yearFY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Income statement
Revenue121098581191539
Revenue growth−9.3%−14.0%−11.7%−8.5%−36.7%48.0%42.6%−21.3%71.8%162.8%
Gross profit000−1012−3410
Research and development——————————
Operating income−1−10−4−3−10−7−2−8
Net income−1−11−4−3−00−6−2−4
Diluted EPS (US$)−0.02−0.020.01−0.05−0.05——−0.06−0.02−0.04
Diluted shares (millions)6767686972—106108109124
Cash flow
Cash from operations01−1−0−1−2−0−52−10
Capital expenditure10110122028
Free cash flow−00−2−1−2−3−2−62−38
Dividends paid0000000100
Share buybacks0000000000
Acquisitions0000000000
Stock-based compensation000000—017
Balance sheet at fiscal year end
Cash and short-term investments000012119121830
Debt incl. finance leases2220000000
Total assets181718141335352835154
Total liabilities67656333613
Shareholders' equity1110118732322629141
Margins and ratios
Gross margin4.5%2.7%0.0%−9.9%3.9%10.8%18.1%−38.5%23.2%25.1%
Operating margin−6.9%−9.4%6.1%−45.4%−63.1%−8.5%3.1%−81.3%−16.0%−21.6%
Net margin−11.0%−11.1%9.7%−44.4%−62.8%−0.8%3.9%−73.0%−11.6%−11.1%
Free cash flow margin−1.4%3.4%−17.2%−9.7%−29.6%−39.8%−17.9%−72.2%12.0%−95.5%
Rule of 40 (growth + FCF margin)−10.7%−10.5%−28.9%−18.2%−66.3%8.2%24.7%−93.5%83.8%67.3%
Return on capital−4.7%−6.0%4.3%−27.5%−34.6%−5.9%2.8%−41.9%−15.5%−11.0%
Return on equity−11.0%−10.4%8.0%−36.9%−42.0%−0.3%1.3%−22.1%−6.4%−5.1%
Return on assets−7.3%−6.5%5.0%−23.5%−24.4%−0.2%1.2%−20.2%−5.5%−4.6%
Net debt to EBITDA10.1x191.3x1.1x——−95.9x−15.0x———
US$ millions unless stated. Where a later 10-K restated a year, the latest filed figure is shown. Download all figures (CSV, US$ millions)
Source: United States Antimony's Form 10-K filings, from SEC EDGAR. For information only, not investment advice. The Filing Desk is not affiliated with United States Antimony.